Investigators compared myeloperoxidase and PR3 ANCA-associated vasculitis. Renal prognoses differed between patients with the myeloperoxidase and PR3 ANCA-associated vasculitis type.
The presence of monoclonal protein in patients who have AAV with renal involvement is associated with higher mortality, according to investigators. Testing for monoclonal protein could help improve assessment of patients with ANCA-associated vasculitis with renal involvement.
Our most-read coverage of American Society of Nephrology Kidney Week 2023 highlighted discussions on the challenges of medication dose adjustments in chronic kidney disease, the impact of LGBTQ+ health care disparities on kidney outcomes, and much more.